Huw M. Nash's most recent trade in Stoke Therapeutics Inc was a trade of 2,467 Common Stock done at an average price of $13.1 . Disclosure was reported to the exchange on July 2, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Stoke Therapeutics Inc | Huw M. Nash | Chief Business Officer | 02 Jul 2024 | 2,467 | 33 (0%) | 0% | 13.1 | 32,320 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | Chief Business Officer | 02 Jul 2024 | 33 | 0 (0%) | 0% | 13.9 | 459 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 20 May 2024 | 50,000 | 0 (0%) | 0% | 15.4 | 769,500 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 20 May 2024 | 50,000 | 46,000 | - | - | Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 20 May 2024 | 50,000 | 50,000 (0%) | 0% | 0.4 | 20,000 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Apr 2024 | 60,929 | 400 (0%) | 0% | 13.2 | 805,768 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Apr 2024 | 50,000 | 96,000 | - | - | Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Apr 2024 | 50,000 | 61,329 (0%) | 0% | 0.4 | 20,000 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Apr 2024 | 400 | 0 (0%) | 0% | 13.6 | 5,444 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 27 Mar 2024 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 27 Mar 2024 | 40,000 | 40,000 | - | - | Restricted Stock Units | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 15 Mar 2024 | 13,100 | 39,300 | - | - | Restricted Stock Units | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 15 Mar 2024 | 13,100 | 15,445 (0%) | 0% | 0 | Common Stock | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 15 Mar 2024 | 4,116 | 11,329 (0%) | 0% | 6.1 | 25,102 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Dec 2023 | 65,600 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Nash Huw M. | COO & CBO | 01 Dec 2023 | 8,463 | 8,463 | - | - | Restricted Stock Unit (RSU) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 15 Mar 2023 | 78,600 | 78,600 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 15 Mar 2023 | 52,400 | 52,400 | - | - | Restricted Stock Unit (RSU) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 15 Mar 2022 | 107,400 | 107,400 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 03 Jan 2022 | 3,800 | 3,800 (0%) | 0% | 2.2 | 8,322 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 03 Jan 2022 | 3,800 | 86,822 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 03 Jan 2022 | 2,103 | 200 (0%) | 0% | 23.4 | 49,219 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 03 Jan 2022 | 1,497 | 2,303 (0%) | 0% | 22.5 | 33,633 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 03 Jan 2022 | 200 | 0 (0%) | 0% | 24.1 | 4,814 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Oct 2021 | 5,700 | 102,022 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Oct 2021 | 5,700 | 0 (0%) | 0% | 24.8 | 141,506 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Oct 2021 | 5,700 | 5,700 (0%) | 0% | 2.2 | 12,483 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Sep 2021 | 5,700 | 5,700 (0%) | 0% | 2.2 | 12,483 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Sep 2021 | 5,700 | 107,722 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Sep 2021 | 5,700 | 0 (0%) | 0% | 26.0 | 148,223 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 02 Aug 2021 | 5,700 | 0 (0%) | 0% | 28.9 | 164,554 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 02 Aug 2021 | 5,700 | 113,422 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 02 Aug 2021 | 5,700 | 5,700 (0%) | 0% | 2.2 | 12,483 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Jul 2021 | 5,700 | 0 (0%) | 0% | 33.3 | 189,987 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Jul 2021 | 5,700 | 119,122 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Jul 2021 | 5,700 | 5,700 (0%) | 0% | 2.2 | 12,483 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Jun 2021 | 575 | 0 (0%) | 0% | 39.4 | 22,669 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Jun 2021 | 575 | 124,822 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Jun 2021 | 575 | 575 (0%) | 0% | 2.2 | 1,259 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 02 Mar 2021 | 65,600 | 65,600 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 04 Jan 2021 | 5,700 | 125,397 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 04 Jan 2021 | 5,700 | 5,732 (0%) | 0% | 2.2 | 12,483 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 04 Jan 2021 | 2,200 | 2,032 (0%) | 0% | 59.0 | 129,837 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 04 Jan 2021 | 1,800 | 232 (0%) | 0% | 59.8 | 107,724 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 04 Jan 2021 | 1,500 | 4,232 (0%) | 0% | 57.7 | 86,494 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 04 Jan 2021 | 200 | 32 (0%) | 0% | 60.5 | 12,102 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 04 Jan 2021 | 32 | 0 (0%) | 0% | 57.1 | 1,828 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 17 Dec 2020 | 41,985 | 180,386 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 17 Dec 2020 | 41,985 | 0 (0%) | 0% | 60 | 2,519,100 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 17 Dec 2020 | 41,985 | 41,985 (0%) | 0% | 0.6 | 25,191 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 17 Dec 2020 | 8,015 | 0 (0%) | 0% | 60 | 480,900 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 17 Dec 2020 | 8,015 | 8,015 (0%) | 0% | 0.6 | 4,809 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 17 Dec 2020 | 8,015 | 172,371 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Dec 2020 | 5,700 | 5,700 (0%) | 0% | 2.2 | 12,483 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Dec 2020 | 5,700 | 131,097 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Dec 2020 | 2,719 | 2,981 (0%) | 0% | 49.2 | 133,744 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Dec 2020 | 2,481 | 500 (0%) | 0% | 50.0 | 124,103 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Dec 2020 | 400 | 0 (0%) | 0% | 52.7 | 21,088 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Dec 2020 | 100 | 400 (0%) | 0% | 51.5 | 5,145 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 10 Nov 2020 | 50,000 | 0 (0%) | 0% | 45 | 2,250,000 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 10 Nov 2020 | 36,586 | 222,371 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 10 Nov 2020 | 36,586 | 36,586 (0%) | 0% | 0.6 | 21,952 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 10 Nov 2020 | 13,414 | 136,797 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 10 Nov 2020 | 13,414 | 50,000 (0%) | 0% | 2.2 | 29,377 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 02 Nov 2020 | 5,700 | 150,211 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 02 Nov 2020 | 5,700 | 5,700 (0%) | 0% | 2.2 | 12,483 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 02 Nov 2020 | 3,164 | 2,536 (0%) | 0% | 36.6 | 115,785 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 02 Nov 2020 | 2,536 | 0 (0%) | 0% | 38.0 | 96,325 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Oct 2020 | 5,700 | 5,700 (0%) | 0% | 2.2 | 12,483 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Oct 2020 | 5,700 | 155,911 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Oct 2020 | 3,400 | 2,300 (0%) | 0% | 34.3 | 116,718 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Oct 2020 | 2,300 | 0 (0%) | 0% | 34.9 | 80,183 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 08 Sep 2020 | 30,718 | 30,718 (0%) | 0% | 2.2 | 67,272 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 08 Sep 2020 | 30,718 | 178,812 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 08 Sep 2020 | 30,718 | 0 (0%) | 0% | 30 | 921,540 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 08 Sep 2020 | 17,201 | 161,611 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 08 Sep 2020 | 17,201 | 0 (0%) | 0% | 30 | 516,030 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 08 Sep 2020 | 17,201 | 17,201 (0%) | 0% | 2.2 | 37,670 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Sep 2020 | 5,700 | 209,530 | - | - | Employee Stock Option (Right to Buy) | ||
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Sep 2020 | 5,700 | 5,700 (0%) | 0% | 2.2 | 12,483 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Sep 2020 | 5,000 | 700 (0%) | 0% | 27.6 | 138,015 | Common Stock | |
| Stoke Therapeutics Inc | Huw M. Nash | COO & CBO | 01 Sep 2020 | 700 | 0 (0%) | 0% | 28.7 | 20,098 | Common Stock |